According to research, up to 50% of patients do not adhere to their treatment. This includes situations when a patient does not take their medication as recommended by their doctor, excessive medication intake, or lack of cooperation with the physician when talking about diet. Nonadherent patients are more prone to unnecessary visits to outpatient clinics and hospitals. To change that, scientists from Poland designed an adherence-improving app that helps patients to take their medication regularly. Gatekeeper’s Reference Use Case 1 was planned to improve adherence among patients with chronic diseases like hypertension, diabetes, and chronic obstructive pulmonary disease.
“My health every day” – an app that helps you to follow your treatmentIf you suffer from a chronic condition and struggle with taking your medications but you would like to boost compliance with your drug regime – the My health every day (Moje zdrowie na co dzień) app is for you. It was designed by the Medication Adherence Research Centre at the Medical University of Lodz, Poland, by a group of researchers and the Head of the Centre, prof. Przemyslaw Kardas.
The app sends individualised hints on how to improve your medication adherence. It takes only one minute a day to collect data about your general well-being and to have a subjective assessment of your medication adherence. Based on that, you will receive evidence-based feedback with best practices on how to improve your compliance and you can also track your daily improvements. As a result, you will become more aware of compliance-enhancing methods, better informed about your condition, which leads to improved medication intake and fewer healthcare visits.
To download the My health every day (Moje zdrowie na co dzień) app, please visit https://mojezdrowie.umed.pl or directly AppStore or Google Play – currently only in Polish. The app is free of charge and includes no advertisements.
Thorough testing by a leading University
The aim of Gatekeeper’s Reference Use Case 7 is to test the app in a special cohort population. 230 participants will be monitored in their adherence to medication – people of the age of 50 or more, with comorbidities, who take at least 5 medications. Depending on the level of the complexity of their situation, patients will either be asked to complete a survey, or their treatment compliance will be measured with a special adherence measuring device. This will also test how the Gatekeeper platform receives healthcare data with different complexity levels. The target population will be reached in cooperation with nursing faculties that have connections in the community. Students of the nursing faculty will disseminate information about the app among patients and will teach them how to use it properly.
The Polish Pilot is one of the 11 Gatekeeper pilots and is hosted by the Medical University of Lodz in the Lodzkie region in Central Poland. Get in touch with the pilot site through the contacts at the end of this post.
The Uniwersytet Medyczny w Łodzi Medical University of Lodz (MUL) is strongly committed to scientific research in several health-related disciplines and is participating in national and international scientific cooperations with almost 10,000 Polish and 800 foreign students. The University has reached leading position in various research areas, particularly in patient adherence and healthy ageing. Serving over 86,000 patients yearly within its own 3 teaching hospitals, MUL is one of the major local healthcare providers, active in every area of modern medicine. In 2021, it created the Medication Adherence Research Centre. As one of the Partners in the Gatekeeper Project, MUL is devoted to the improvement of doctor-to-patient communication, especially in the field of medication adherence.
Get in touch!
If you are interested in the Gatekeeper project, stay tuned through our social networks, webinars and newsletter.
Follow the project:
- Gatekeeper Project Website
- Gatekeeper LinkedIn Group
- Gatekeeper Twitter Account (@Gatekeeper_EU)
- Gatekeeper YouTube Channel
To contact the MUL pilot site: